SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Genesys (CEGE)
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
1298 85 0 CEGE
Emcee:  Bharat Kalra Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1223Ceregene Exclusively Licenses Neurturin Gene From Washington University WednesdSemiBull-12/4/2002
1222Ceregene Elects Raymond Bartus Vice President of Research and Development ThursSemiBull-11/14/2002
1221Cell Genesys Completes Construction of Manufacturing Facility for Phase III ClinSemiBull-11/10/2002
1220Cell Genesys Reports Third Quarter Financial Results Monday October 21, 4:01 pmSemiBull-10/21/2002
1219>>FOSTER CITY, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Cell Genesys, Inctuck-10/18/2002
1218Ceregene Awarded SBIR Grant From NIH for Alzheimer's Research Tuesday OctoSemiBull-10/15/2002
1217Thanks. <EOM>John Liu-9/3/2002
1216Since 1996, the Company has maintained an investment in Abgenix. In December 199tom pope-9/3/2002
1215Does anyone know approx. how many shares of ABGX does Cell Genesys still owns? John Liu-9/3/2002
1214>>FOSTER CITY, Calif., Aug. 15 /PRNewswire-FirstCall/ -- Cell Genesys, Inctuck-8/15/2002
1213MLNM, ISIS, ICOS and AMLN.SemiBull-8/9/2002
1212what are the other four?Valery Portnov-8/9/2002
1211<i>I still believe that CEGE and ABGX are one of the better funded biotechSemiBull-8/8/2002
1210Pretty impressive move today imo, also ABGX was up smartly. I still believe thatValery Portnov-8/8/2002
1209Cell Genesys Promotes Three Members of Executive Management Team FOSTER CITY, CSemiBull-8/8/2002
1208Cell Genesys Reports Second Quarter Results Ends Quarter With $229 Million in CSemiBull-7/22/2002
1207I try to be objective in reading these CEGE trial updates -- but the fact is tha249443-6/27/2002
1206Cell Genesys Reports Encouraging Follow-Up Data From Phase I/II Trial of GVAX(R)SemiBull-6/27/2002
1205Thanks for the article. (I added a little more to my small position today.)Paul Senior-6/12/2002
1204biz.yahoo.com BusinessWeek Online This Biotech Has a Strong Pulse Daily BriefiExacctnt-6/12/2002
1203Cell Genesys Reports Clinical Scale Production Capabilities for Lentiviral Gene SemiBull-6/11/2002
1202Cell Genesys Licenses Gene Activation Intellectual Property to TKT for Certain TSemiBull-6/10/2002
1201Cell Genesys and EntreMed Report Positive Preclinical Studies Of AntiangiogenesiSemiBull-6/6/2002
1200Cell Genesys, Inc. Invites You to Join Its Company Presentation At the Needham &SemiBull-6/2/2002
1199Cell Genesys Initiates Phase II Trial of GVAX(R) Cancer Vaccine in Patients WithSemiBull-5/29/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News